Genpact (NYSE:G) Issues Earnings Results, Misses Estimates By $0.11 EPS

Genpact (NYSE:GGet Free Report) released its quarterly earnings data on Thursday. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.93 by ($0.11), Zacks reports. Genpact had a net margin of 11.01% and a return on equity of 22.55%. Genpact updated its FY 2026 guidance to 4.010-4.010 EPS and its Q1 2026 guidance to 0.920-0.930 EPS.

Genpact Stock Performance

NYSE G traded down $0.69 on Thursday, hitting $37.65. 4,793,717 shares of the company traded hands, compared to its average volume of 1,756,398. The company has a current ratio of 1.51, a quick ratio of 1.51 and a debt-to-equity ratio of 0.33. The business’s 50 day moving average price is $46.12 and its 200-day moving average price is $43.83. The company has a market capitalization of $6.49 billion, a price-to-earnings ratio of 12.15, a P/E/G ratio of 1.15 and a beta of 0.74. Genpact has a 52-week low of $37.49 and a 52-week high of $56.76.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on G. Susquehanna assumed coverage on shares of Genpact in a research note on Friday, December 12th. They issued a “neutral” rating and a $50.00 price target for the company. Weiss Ratings reiterated a “hold (c+)” rating on shares of Genpact in a research note on Friday, December 26th. Wall Street Zen upgraded Genpact from a “hold” rating to a “buy” rating in a research note on Saturday, January 10th. Finally, Citigroup upgraded Genpact to a “hold” rating in a research report on Thursday, October 23rd. Two equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Genpact currently has a consensus rating of “Hold” and a consensus price target of $50.50.

View Our Latest Research Report on G

Insider Transactions at Genpact

In other news, Director Tamara Franklin sold 2,750 shares of Genpact stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $45.65, for a total transaction of $125,537.50. Following the transaction, the director directly owned 22,236 shares of the company’s stock, valued at $1,015,073.40. The trade was a 11.01% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Riju Vashisht sold 16,016 shares of the stock in a transaction that occurred on Tuesday, January 13th. The stock was sold at an average price of $46.65, for a total transaction of $747,146.40. Following the completion of the sale, the senior vice president directly owned 95,521 shares of the company’s stock, valued at $4,456,054.65. This represents a 14.36% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 60,385 shares of company stock valued at $2,762,475 over the last quarter. 3.07% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Genpact

Institutional investors have recently bought and sold shares of the business. AQR Capital Management LLC lifted its position in shares of Genpact by 170.4% in the third quarter. AQR Capital Management LLC now owns 3,443,472 shares of the business services provider’s stock valued at $144,247,000 after acquiring an additional 2,170,145 shares in the last quarter. Ameriprise Financial Inc. raised its stake in Genpact by 34.1% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,166,489 shares of the business services provider’s stock valued at $95,347,000 after purchasing an additional 551,269 shares during the period. Invesco Ltd. lifted its holdings in Genpact by 52.9% in the 3rd quarter. Invesco Ltd. now owns 2,145,762 shares of the business services provider’s stock worth $89,886,000 after purchasing an additional 742,470 shares in the last quarter. UBS Group AG boosted its stake in Genpact by 140.5% in the 3rd quarter. UBS Group AG now owns 1,007,358 shares of the business services provider’s stock worth $42,198,000 after purchasing an additional 588,449 shares during the period. Finally, Balyasny Asset Management L.P. grew its holdings in Genpact by 7.6% during the 2nd quarter. Balyasny Asset Management L.P. now owns 892,778 shares of the business services provider’s stock valued at $39,291,000 after buying an additional 63,156 shares in the last quarter. Hedge funds and other institutional investors own 96.03% of the company’s stock.

About Genpact

(Get Free Report)

Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.

Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.

Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.

Read More

Earnings History for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.